Trailing-twelve-month (TTM) revenue is $2.53 Billion with a year-over-year growth of (0.05%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $634,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $636,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-20 |
| Q1 FY2026Period ended 2026-03-31 | $629,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $631,500,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $2,531,600,000 |
Current P/S: $8,628,034,838 market capitalization ÷ $2,531,600,000 TTM revenue = 3.41x.
Market capitalization source: FMP quote. Quote observed 2026-10-02T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $631.50M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-02T21:30:26.152Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $915M | $1.0B | $1.1B | $1.1B | $1.1B | $1.1B |
| UNITED STATES | $999M | $1.1B | $1.3B | $1.4B |
$2.53B
$2.53 Billion
(0.05%)
vs. $2.53B a year ago (TTM)
+4.48%
5 Year compound annual growth rate
1 Year
(0.05%)
3 Year
+1.47%
5 Year
+4.48%
10 Year
+15.36%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.52B | ($27.20M) | (1.07%) |
| 2024 | $2.55B | +$46.60M | +1.86% |
| 2023 | $2.50B | +$176.70M | +7.60% |
| 2022 | $2.32B | +$167.00M | +7.74% |
| 2021 | $2.16B | +$244.00M | +12.75% |
| 2020 |
TTM Growth
(0.05%)
3-Year CAGR
+1.47%
5-Year CAGR
+4.48%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 38 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-02T21:30:26.152Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
| $1.4B |
| $1.91B |
| +$252.60M |
| +15.20% |
| 2019 | $1.66B | +$269.60M | +19.37% |
| 2018 | $1.39B | +$284.90M | +25.74% |
| 2017 | $1.11B | +$262.00M | +31.01% |
| 2016 | $844.80M | +$241.00M | +39.91% |
